Angina
📧 Sign up to get email alerts when something new happens for Angina.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: Efficacy of the COronary SInus Reducer in Patients With Refractory Angina II [NA]
Clinical trial update indicating active recruitment for evaluating the Coronary Sinus Reducer in patients with refractory angina; no efficac…
-
CLINICAL_TRIALS research · 2026-04-07Clinical Trial Update: LIVEBETTER: A Trial Comparing Medications in Older Adults With Stable Angina and Multiple Chronic Conditions [Phase 4]
This is a Phase 4 clinical trial update for LIVEBETTER, a study comparing medications in older adults with stable angina and multiple chroni…
-
CLINICAL_TRIALS trial_result · 2026-03-09Clinical Trial Update: Wave Crossover ECP Study for Simplified Therapy [NA]
Completed clinical trial update for the Wave Crossover ECP Study evaluating simplified therapy in chronic stable angina and refractory angin…
-
CLINICAL_TRIALS research · 2026-01-07Clinical Trial Update: Assessing the Safety and Effectiveness of Intracoronary Stem Cells in Patients With Refractory Angina [Phase 2]
A Phase 2 clinical trial is evaluating the safety and effectiveness of intracoronary stem cells in patients with refractory angina and is cu…
-
CLINICAL_TRIALS research · 2026-01-06Clinical Trial Update: CardiAMP Cell Therapy Chronic Myocardial Ischemia Trial [NA]
The CardiAMP Cell Therapy trial for refractory angina and chronic myocardial ischemia remains active but not recruiting.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2025-11-10Clinical Trial Update: A Study to Evaluate the Safety, Tolerability, and Efficacy of IMB-1018972 in Patients With Refractory Angina [Phase 2]
A Phase 2 study of IMB-1018972 for refractory angina was withdrawn; no results reported.
-
CLINICAL_TRIALS research · 2025-04-16Clinical Trial Update: Imaging Coronary Microvascular Dysfunction (CMD) Study [NA]
A clinical trial update for an imaging study of coronary microvascular dysfunction, currently recruiting, involving angina and non-obstructi…
-
CLINICAL_TRIALS trial_result · 2025-04-06Clinical Trial Update: Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for Heart Disease [Phase 1]
Phase 1 safety trial evaluating cultured allogeneic umbilical cord-derived mesenchymal stem cells for heart disease has been terminated.
-
CLINICAL_TRIALS trial_result · 2025-04-03Clinical Trial Update: Coronary Sinus Reducer Implantation in Patients With Ischaemia and Non-obstructed Coronary Arteries and Coronary Microvascular Dysfunction. [NA]
A clinical trial update indicates that Coronary Sinus Reducer implantation is being evaluated for patients with ischemia and non-obstructed …
-
CLINICAL_TRIALS trial_result · 2025-03-24Clinical Trial Update: The Anti-Anginal Effects of N-Acetylcysteine (NAC) in Patients with Angina and Non-Obstructive Coronary Arteries (ANOCA) [Phase 2]
Phase 2 clinical trial update investigating the anti-anginal effects of N-acetylcysteine in patients with angina and non-obstructive coronar…
-
CLINICAL_TRIALS research · 2024-07-16Clinical Trial Update: Coronary Microvascular Dysfunction in Angina Patients With Non-obstructive Coronary Artery Disease (ANOCA-CMD)
A recruiting clinical trial investigating coronary microvascular dysfunction in patients with angina and non-obstructive coronary arteries (…
-
CLINICAL_TRIALS trial_result · 2021-02-24Clinical Trial Update: Allopurinol in Patients With Refractory Angina to Improve Ischemic Symptoms [Phase 2, Phase 3]
Clinical trial update for allopurinol in patients with refractory angina across Phase 2 and Phase 3 stages.
-
CLINICAL_TRIALS trial_result · 2021-01-28Clinical Trial Update: Double Blind Atorvastatin Amlodipine Study [Phase 4]
Phase 4 trial update on double-blind atorvastatin and amlodipine study completed.
-
CLINICAL_TRIALS trial_result · 2020-11-10Clinical Trial Update: Effect of Low-dose vs. High-dose Pitavastatin on In-stent Restenosis [Phase 4]
Phase 4 trial comparing low-dose versus high-dose pitavastatin effects on in-stent restenosis.
-
CLINICAL_TRIALS trial_result · 2020-10-27Clinical Trial Update: Topical Nitroglycerine Treatment for Radial Artery Spasm Prevention [Phase 4]
Phase 4 trial update evaluating topical nitroglycerine to prevent radial artery spasm, with completed status and results posted.
-
FDA approval · 2020-08-18FDA Approved: RANOLAZINE — Supplemental Application (Lupin Pharmaceuticals, Inc.)
FDA approved Lupin Pharmaceuticals' supplemental application for ranolazine, enabling a generic version of the heart medicine to be marketed…
-
CLINICAL_TRIALS trial_result · 2020-06-05Clinical Trial Update: The Value of CT Fractional Flow Reserve
Clinical trial update on CT Fractional Flow Reserve for angina and stable chest pain; study completed with results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2020-05-04Clinical Trial Update: Crushed Ticagrelor Versus Eptifibatide Bolus + Clopidogrel [Phase 2]
Phase 2 trial comparing crushed ticagrelor to eptifibatide bolus plus clopidogrel in acute coronary syndrome and unstable angina; study comp…
-
FDA approval · 2020-03-23FDA Approved: RANOLAZINE — Original Application (SunGen Pharma LLC)
FDA approves SunGen Pharma LLC's original application for a generic ranolazine product (Ranolazine) to treat chronic angina.
-
FDA approval · 2020-03-15FDA Approved: RANOLAZINE — Supplemental Application (Actavis Pharma, Inc.)
FDA approved a supplemental application for ranolazine submitted by Actavis Pharma, Inc.
-
FDA approval · 2020-02-25FDA Approved: RANOLAZINE — Supplemental Application (Lupin Pharmaceuticals, Inc.)
FDA approved Lupin Pharmaceuticals' supplemental application to market a generic Ranolazine product. This approval pertains to a generic ver…
-
FDA approval · 2020-02-24FDA Approved: RANOLAZINE — Supplemental Application (Ajanta Pharma USA Inc.)
FDA approved a supplemental application for Ranolazine from Ajanta Pharma USA Inc., enabling updated labeling for the generic product.
-
CLINICAL_TRIALS trial_result · 2019-11-18Clinical Trial Update: A Safety Study of ABI-007 for In-Stent Restenosis [Phase 2]
Phase 2 safety study of ABI-007 for in-stent restenosis has completed.
-
CLINICAL_TRIALS trial_result · 2019-11-12Clinical Trial Update: Lipoprotein Apheresis in Refractory Angina Study [NA]
Clinical trial update on lipoprotein apheresis for refractory angina with elevated Lipoprotein(a); study completed with results posted in 20…
-
FDA approval · 2019-10-31FDA Approved: RANOLAZINE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a supplemental application for ranolazine under Sun Pharmaceutical Industries’ ANDA211707. This approval updates the status of …